Milla Pharmaceuticals

Milla Pharmaceuticals, headquartered in Minnetonka, Minnesota, is a subsidiary of the Belgian pharmaceutical group, A.forall. Operating as a smaller entity within the larger organization, Milla Pharmaceuticals focuses specifically on the development, licensing, acquisition, and commercialization of generic prescription drugs. Milla Pharmaceuticals specializes in niche injectable and solution products, targeting hospitals and clinics across the United States. Their portfolio caters to specific medical needs, offering alternative solutions for patients requiring specialized medications. A.forall, Milla Pharmaceuticals' parent company, boasts a global presence, distributing pharmaceutical products to various sectors, including pharmacies, wholesalers, hospitals, and retirement homes. Their extensive portfolio encompasses approximately 30 molecules marketed across Europe and the United States, demonstrating a commitment to providing accessible pharmaceutical solutions worldwide. Milla Pharmaceuticals can be reached through their website, millapharmaceuticals.com.